Acel Pharma Private Limited - Company Profile

It is a home appliances private limited company based in Pune, Maharashtra, India, established in 2010.
2010 Pune, Maharashtra, India Struck Off
Last Updated:
Access Report
About Acel Pharma Private Limited

Acel Pharma Private Limited, a struck off private limited company, was established on 30 August 2010 in Pune, Maharashtra, India. Engaging in retailers within the home appliances sector, it holds CIN: U52310PN2010PTC137234. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Arvind Baburao Kolsure (Director), Varsha Arvind Kolsure (Director). Past directors included Jagannath Madhavrao Kadus, Sandip Jagannath Kadus, Dattatraya Pandharinath Thore. Its latest AGM occurred on 30 September 2011, with the balance sheet filed on 31 March 2011. It is based at Sn No 244/A/1, Kunal Plaza, Sh No. 37 Dava Bazar, Chinchawad, Pune, Maharashtra, 411019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52310PN2010PTC137234

  • Registration Number

    137234

  • Incorporation Date

    30 August 2010

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 8 Months
  • Last Filing with ROC 31 Mar 2011
Company report

Acel Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Acel Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Acel Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Arvind Baburao Kolsure Director 24 May 2013 Current
Varsha Arvind Kolsure Director 24 May 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 May 2013 Past
Pramod Abcsdd Director 27 Dec 2010 Past
Pramod Abcsdd Director 12 Dec 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Acel Pharma.

Enhance accessibility to Acel Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Acel Pharma revenue growth over time
Acel Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Acel Pharma?

Unlock access to Acel Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Acel Pharma?

Unlock and access historical data on people associated with Acel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Acel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acel Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Acel Pharma
Recent Activity within the Organization
  • Director Appointment

    Arvind Baburao Kolsure was appointed as a Director was appointed as a Director on 24 May 2013 & has been associated with this company since 12 years 11 months . was recorded as a recent event.

  • Director Appointment

    Varsha Arvind Kolsure was appointed as a Director was appointed as a Director on 24 May 2013 & has been associated with this company since 12 years 11 months . was recorded as a recent event.

  • Annual General Meeting

    Acel Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2011 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Acel Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Pune. was completed.

  • Company Incorporation

    Progress on Acel Pharma Private Limited was registered on 30 Aug 2010 with Roc Pune & aged 15 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Acel Pharma Private Limited?

The CIN of Acel Pharma Private Limited is U52310PN2010PTC137234.

Where is Acel Pharma Private Limited headquartered?

Acel Pharma Private Limited is headquartered at Sn No 244/A/1, Kunal Plaza, Sh No. 37 Dava Bazar, Chinchawad, Pune, Maharashtra, 411019.

When was Acel Pharma Private Limited incorporated?

Acel Pharma Private Limited was incorporated on 30 August 2010.

Who are the current directors of Acel Pharma Private Limited?

The current directors of Acel Pharma Private Limited are

What is the primary industry of Acel Pharma Private Limited?

The primary industry of Acel Pharma Private Limited is Home Appliances.

Is Acel Pharma Private Limited a listed company?

Acel Pharma Private Limited is unlisted.

What is the capital structure of Acel Pharma Private Limited?

The authorized capital of Acel Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available